Loading provider…
Loading provider…
Hematology & Oncology Physician in Mission Hills, CA
NPI: 1174522585Primary Practice Location
PROVIDENCE HOLY CROSS MED CTR D/P SNF
11600A INDIAN HILLS ROAD, MISSION HILLS, CA 91345, Mission Hills, CA
Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get MD Shamel's Phone Numberphone_androidMobile
Get MD Shamel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1980 - 2025

American Board of Internal Medicine
Internal Medicine
University at Buffalo
Fellowship • Hematology and Medical Oncology
1977 - 1979
University at Buffalo (Catholic Health System--Sisters of Charity)
Residency • Internal Medicine
1975 - 1977
Saint Lukes Cornwall Hospital
Internship • Transitional Year
1974 - 1975
Tehran University of Medical Sciences School of Medicine
Medical School
Until 1972
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 248 | 608 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 156 | 665 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 92 | 124 |
| 4 | 96413Infusion of chemotherapy into a vein up to 1 hour | 68 | 322 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 65 | 263 |
Authors: Robert Vescio, Youram Nassir, Chien-Shing Chen, James Berenson, Veena Charu, Thomas Woliver
Journal: Support Care Cancer
Publication Date: 2014-11-05
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.
Authors: Ashkan Sefaradi, Ian Flinn, Gargi Upadhyaya, Charles Farber, John Crowley, Albert Shamouelian, Natasha Tiffany, Harry Staszewski, Donald Gravenor
Publication Date: 2010-12-02
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Cancer and Leukemia Group B, NSABP Foundation Inc, SWOG Cancer Research Network, NCIC Clinical Trials Group, North Central Cancer Treatment Group, American College of Surgeons
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Exemestane, DRUG: Letrozole, DRUG: Anastrozole, DRUG: Tamoxifen Citrate